Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07663136 · ClinicalTrials.gov registry record · NA
Finding Immune Nascent Type 1 Diabetes
A NA study, sponsored by Indiana University.
- Not yet
- Registry status
- NA
- Development phase
- 3,800
- Enrollment target
NCT07663136: Clinical Trial NA study, sponsored by Indiana University.
NCT07663136 is a NA study that has not yet begun recruiting, run by Indiana University. The registered enrollment target is 3,800 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (171% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07663136, a NA study, has not yet begun recruiting, sponsored by Indiana University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 3,800 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is: What form of recruitment communication is most effective for completing a type 1diabetes home screening kit? Researchers will compare two types of recruitment contact: email and mail based communication (low-touch) versus phone contact and follow-up by a research team member (high-touch). Participants will be contacted either via email/mail or by phone and asked if they want to complete a type 1 diabetes home screening kit.
Primary Outcome
The number of returned screening kits versus the number that were not returned by consented participants.
Interventions
- BEHAVIORAL phone call
- BEHAVIORAL email/mail
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,800 participants |
| Start Date | 2026-06 |
| Est. Completion | 2029-06 |
| Phase | NA |
What is known before NCT07663136 opens enrollment
NCT07663136 is an interventional study that assigns participants to a tested intervention. Its 3,800 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (171% higher).
The record links to 0 conditions, and to 2 interventions - of which phone call is the first listed.
NCT07663136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07663136 about?
NCT07663136 is a clinical study titled "Finding Immune Nascent Type 1 Diabetes". The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is: What form of recruitment commu...
What is the current status of trial NCT07663136?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 3,800 participants. The study started on 2026-06. Estimated completion is 2029-06.
What interventions are being tested in trial NCT07663136?
The interventions under investigation include: phone call (BEHAVIORAL), email/mail (BEHAVIORAL).
Who is sponsoring clinical trial NCT07663136?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07663136's enrollment target sits among peer trials
3,800 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04573660 · 3,784 participants
Abbott Vascular Medical Device Registry
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- NCT06172660 · 3,750 participants
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
- NCT06298253 · 3,750 participants · NA
Behavioral Economics to Implement a Traffic Light Nutrition Ranking System: Study 2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia